Adults who have Chronic Spontaneous Urticaria (hives) may qualify for this clinical research trial and receive investigational injectable medication or placebo.
- Age ≥ 18
- CSU diagnosis ≥ 6 months
- Persistent hives and/or angioedema for ≥ 6 weeks consecutively at any time after, despite treatment with a second-generation H1 antihistamine (H1AH)
- Documented use of a stable dose of a H1AH ≥ 4 weeks
Participants will be asked to visit the clinic about 19 times over a 72-week period. There is no cost to participate, and participants will be reimbursed for their travel and time.
For further information on the study, please follow the link
Trial ID: NCT06445023